These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3362823)
1. [Use of antioxidants and lidase in pulmonary tuberculosis]. Gur'eva IG; Andrzheiuk NI; Starostenko EV; Smirnova NA; Elistratova NA Probl Tuberk; 1988; (1):52-6. PubMed ID: 3362823 [No Abstract] [Full Text] [Related]
2. [Comprehensive antibacterial therapy in combination with lidase of respiratory organ tuberculosis in children and adolescents]. Firsova VA; Bolotnikova VA Probl Tuberk; 1979 Mar; (3):35-8. PubMed ID: 370821 [No Abstract] [Full Text] [Related]
3. [Radioisotope scanning of the lungs of patients with destructive pulmonary tuberculosis during treatment with antibacterial drugs and lidase]. Grigaliunas AP Probl Tuberk; 1975; (5):45-7. PubMed ID: 1144343 [No Abstract] [Full Text] [Related]
4. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis]. Grigaliunas AP Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837 [No Abstract] [Full Text] [Related]
5. [Antioxidants--effective pathogenetic agents in the combined therapy of pulmonary tuberculosis]. Gur'eva IG; Starostenko EV; Narovlianskaia SE Ter Arkh; 1987; 59(7):72-4. PubMed ID: 3672365 [TBL] [Abstract][Full Text] [Related]
6. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis]. Skakun NL; Blikhar EI Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163 [TBL] [Abstract][Full Text] [Related]
7. [Pathogenetic therapy in pulmonary tuberculosis]. Starostenko EV Probl Tuberk; 1989; (5):22-6. PubMed ID: 2748555 [TBL] [Abstract][Full Text] [Related]
8. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients]. Starostenko EV; Andrzheiuk NI; Salpagarov AM Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950 [No Abstract] [Full Text] [Related]
9. [Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents]. Firsova VA; Rusakova LI; Gubkina MF; Ryzhova AP; Panova LV; Kobulashvili MG; Poluéktova FG; Iatskova TV Probl Tuberk; 2001; (7):21-3. PubMed ID: 11763555 [TBL] [Abstract][Full Text] [Related]
10. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy]. Ubaĭdullaev AM; Belotserkovskiĭ VG Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948 [TBL] [Abstract][Full Text] [Related]
11. [Effect of bronchial pathology on the results of treatment of pulmonary tuberculosis]. Shesterina MV; Kim ACh; Agafonnikova KI; Rzhavskov IuV; Barchakhova ZI Probl Tuberk; 1974; (8):21-3. PubMed ID: 4409353 [No Abstract] [Full Text] [Related]
12. [Hyaluronidase in complex treatment of tuberculous and metatuberculous lesions of the respiratory organs in children and adolescents]. Kibrik BL; Khitrina GV Probl Tuberk; 1975; (3):48-51. PubMed ID: 1079600 [No Abstract] [Full Text] [Related]
13. [The effect of hyaluronidase on morphologic ractions in experimental tuberculosis]. Khitrina GV Probl Tuberk; 1971; 49(12):68-74. PubMed ID: 5159692 [No Abstract] [Full Text] [Related]
14. [Antitubercular chemotherapy--its current status and outlook]. Moisescu V Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):15-26. PubMed ID: 2847296 [No Abstract] [Full Text] [Related]
15. [The effect of short-term treatment on the evolution toward chronicity of pulmonary tuberculosis]. Basacopol A; Alexandrescu D; Stanciu M Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):177-9. PubMed ID: 2555905 [No Abstract] [Full Text] [Related]